Clinical trial · Observational
Clinical Evaluation of Genetron IDH1 PCR Kit in Glioma Patients
NCT05100173CI-TRIAL-00055160completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this trail is to evaluate the performance of Genetron IDH1 PCR Kit in Glioma patients using real-time PCR method.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Glioma, Malignant | Malignant Glioma | ALIAS | 0.90 |
| Glioma, Mixed | Mixed Glioma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Efficacy of the Genetron IDH1 PCR Kit
- timeFrame
- 3 months
- description
- The main purpose of this study is: by evaluating the Genetron IDH1 PCR Kit to compare the results of the Sanger sequencing method, and to calculate the coincidence rate and consistency of the two methods.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1. Enroll cases in strict accordance with the requirements of the study 2. The remaining samples after routine clinical testing 3. The collection and processing of samples meet the requirements of standard laboratory operations and product instructions 4. The relevant information of the sample is complete, including sample number, gender, age, and possible clinical diagnosis information 5. Each sample must have HE staining results (hematoxylin-eosin staining) 6. Pathological examination diagnosed as glioma, other brain tumors or normal tissues 7. Number of samples: 10 pieces of each sample with a thickness of 10μm, and the tumor content is not less than 50% Exclusion Criteria: 1. Incomplete sample information 2. Severely contaminated samples 3. Samples that do not meet the requirements of sample collection and processing
References
Publications (0)
Data not yet available
No reference posted for this study.